|
|
 |
|
Viewing report
|
|
|
|
Malaria Patent Landscape - 2009/08
France Innovation Scientifique et Transfert (FIST SA), Aug 2009, Pages: 134
IP Overview Malaria presents a patent landscape analysis of the Malaria field.
Since the discovery of the parasite responsible for Malaria in 1880, this disease has been the subject of intensive research and development within the academic and industrial sectors with a first patent filed as early as 1907 describing a quinine based treatment. Despite the small market (~1 billion $) generated by the drugs currently commercialized, more than 3000 patents describing new ways to control malaria were filed since 1980 with a growing interest over the last decade.
Next to a very dynamic institutional research, some industrials are marking out their position expecting increased reputation, but also with the hope of public and private funding and growing solvability of currently infected countries. New collaborations are forming and companies emerge on very specific segments. With upcoming resistances, current challenges in controlling malaria consist in developing early rapid diagnostic tests, efficient and affordable preventive and curative drugs and vaccines but also in developing efficient insecticides and repellents. The R&D and patent strategy in this sector bring forth the interest of these three challenges.
In the current race for controlling malaria, this IP Overview provides you a comprehensive panorama of the intellectual property landscape and helps you:
- Position your company’s R&D and IP Portfolio
- Identify key inventors and key players involved in specific thematic
- Understand the collaboration networks and theirs dynamics
- Uncover trends and emerging segments
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Malaria Vaccines: Commercial Prospects and Landscape Analysis
Monoclonal Antibodies Against Digestive System Cancers Patent Landscape 2010
Human Vaccines - Global Strategic Business Report
World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast
Adult and Adolescent Vaccines Market to 2017 - Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010
Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market
Future Infectious Disease Testing Market: Growth Opportunities and Business Expansion Strategies
Drug Delivery in Cancer - Technologies, Markets and Companies
Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing
Seasonal Influenza Vaccine Market in Asia-Pacific Region - Cell Culture Technology-Based Vaccines to Revolutionize the Market by Faster Production and High Initial Purity
|
|
|
|
